William Goolsbee
Director/Board Member at HELIX BIOMEDIX, INC.
Profile
William Alden Goolsbee was the founder of Horizon Medical, Inc. (founded in 1987) where he held the title of Chairman & Chief Executive Officer in 2002.
He is currently the Chairman & Chief Executive Officer at BMG Hematology LLC and an Independent Director at Helix BioMedix, Inc. He previously served as Chairman of Immunotherapy Corp.
from 1995 to 1998, Chairman of BMG Pharma LLC from 2006 to 2011, Chairman of Metrodora Therapeutics, Inc., Independent Director at Sarepta Therapeutics, Inc. from 2014 to 2016, and Independent Non-Executive Director at Percheron Therapeutics Ltd.
from 2015 to 2021.
Mr. Goolsbee obtained his undergraduate degree from the University of California, Santa Barbara.
William Goolsbee active positions
| Companies | Position | Start |
|---|---|---|
| HELIX BIOMEDIX, INC. | Director/Board Member | 01/01/2019 |
| BMG Hematology LLC | Chief Executive Officer | - |
Former positions of William Goolsbee
| Companies | Position | End |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Director/Board Member | 15/12/2021 |
| SAREPTA THERAPEUTICS, INC. | Chairman | 30/07/2014 |
| Metrodora Therapeutics, Inc. | Chairman | 01/01/2015 |
| BMG Pharma LLC | Chairman | 01/01/2011 |
| Horizon Medical, Inc. | Chief Executive Officer | 01/01/2002 |
Training of William Goolsbee
| University of California, Santa Barbara | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| Private companies | 5 |
|---|---|
| Horizon Medical, Inc. | Health Technology |
Immunotherapy Corp.
 Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The private company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million. | Health Technology |
| BMG Pharma LLC | |
| BMG Hematology LLC | |
| Metrodora Therapeutics, Inc. |
- Stock Market
- Insiders
- William Goolsbee